[{"_1":2,"_110":-5,"_111":-5},"loaderData",{"_3":4,"_26":27},"root",{"_5":6,"_17":10,"_18":19,"_20":21,"_22":10,"_23":-5,"_24":-5,"_25":10},"user",{"_7":8,"_9":10,"_11":10,"_12":-5,"_13":-5,"_14":15,"_16":-5},"roles",[],"isAuthenticated",false,"isPremium","planName","subscriptionStatus","featureFlags",{},"insightsBudget","isDevelopmentHost","userPreferences",{},"recaptchaSiteKey","6LcvOJcUAAAAAHsB-gPGfGktcRlKpH7OTIU_dMTD","isImpersonating","impersonation","affiliateStatus","isFreedomPortal","routes/v2/article/layout",{"_28":29,"_30":31},"notFound",true,"relatedArticles",[32,75,87,99],{"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":48,"_49":50,"_51":52,"_53":54,"_55":56,"_57":58,"_59":60,"_61":62,"_63":64,"_65":66,"_67":68,"_69":70,"_71":72,"_73":72,"_74":72},"mediaId",6141932,"mediaKeyId","5569697-a6a320e7ca35afd02dae6cb260887859","parentId",5569697,"title","Committee reports four nominees to the Senate after roll‑call votes","audioSeconds",192,"startMs",5278000,"endMs",5470000,"viewUrl","/Search/View?dp=1&key=5569697-a6a320e7ca35afd02dae6cb260887859&start=5278&end=5470","thumbnailUrl","https://assets.pipeline.soar.com/5569697-a6a320e7ca35afd02dae6cb260887859/thumbnail_5278000.jpg","articleUrl","/articles/6141932/Committee-reports-four-nominees-to-the-Senate-after-rollcall-votes","mediaUrl","https://secure.pipeline.soar.com/6141932-83766c808fd9168e0453ab3310ce5297/orig.mp4?Expires=1770505223&Signature=c23UM6CcIY8ZUbUZSX9rU8cBZOLgK~UbpxdXa-25vH~xDr-3kt9dnG0vsgNZFI0De~loiPt-CSIsB0JTFOwvYpj4q6g5QiD0qvchEjsjjcgMylfkJJg3XWHLdP7gkxUgVHFsss7YgIAaTDzuZSAmdfxaqEetc7So1wp17DSzyQ-D5e-993ke2RBut~yzCNsckDLq9oFHXi9v9yDbfDQlxen5RaO5ZkF-pRp-yyp7liL6L0uWyM9VzhjCFicOpWRV0ZUqKV~3eKh2sj0FnjuoTeHBKgUcwe~Xvk7OXyJEQieOgS12nb8U9aQbfTNmqk2yKvs~CKFnS9RC8W~y-Hoa0Q__&Key-Pair-Id=KUT5TJCACFTXG","author","U.S. Senate Committee on Homeland Security and Governmental Affairs","date","2025-07-30T00:00:00Z","article","The committee voted to report four presidential nominees to the full Senate following roll‑call votes taken at the end of the March 12 markup.

The clerk called the roll for each nominee. The committee announced the following outcomes as recorded in the transcript: Pedro Allende (motion to report agreed; announced yeas 8, nays 7), Sean Planky (Director, Cybersecurity and Infrastructure Security Agency — reported yeas 9, nays 6), Christopher Fox (Inspector General, Intelligence Community Office — reported yeas 8, nays 7), and Edward O’Connell (associate judge, Superior Court of the District of Columbia — reported yeas 15, nays 0). The clerk’s announcements included proxy votes where applicable and the chair declared the motions to report the nominees agreed to in each instance.

The transcript does not include full biographical detail, the text of nomination materials, or the committee’s committee‑report language. The clerk’s roll calls are the formal recorded committee actions reflected in the transcript; the nominations will proceed according to Senate floor procedures and scheduling.","mediaType","Video","parentTitle","Business Meeting","oneSentenceSummary","The committee voted to report four presidential nominees — Pedro Allende, Sean Plankey (listed as Sean Planky in transcript), Christopher Fox, and Edward O’Connell — to the full Senate, with recorded roll calls for each nomination.","taxTitle","Homeland Security and Governmental Affairs: Senate Committee, Standing Committees - House & Senate, Congressional Hearings Compilation, Legislative, Federal","taxId",1996,"location","","headline","shortSummary",{"_33":76,"_35":36,"_37":38,"_39":77,"_41":78,"_43":79,"_45":80,"_47":81,"_49":82,"_51":83,"_53":84,"_55":56,"_57":58,"_59":85,"_61":62,"_63":64,"_65":86,"_67":68,"_69":70,"_71":72,"_73":72,"_74":72},6141937,"Committee adopts modified ‘Pelosi Act’ banning members from owning individual stocks; modification exempts sitting president from required divestiture",4104,1180000,5284000,"/Search/View?dp=1&key=5569697-a6a320e7ca35afd02dae6cb260887859&start=1180&end=5284","https://assets.pipeline.soar.com/5569697-a6a320e7ca35afd02dae6cb260887859/thumbnail_1180000.jpg","/articles/6141937/Committee-adopts-modified-Pelosi-Act-banning-members-from-owning-individual-stocks-modification-exempts-sitting-president-from-required-divestiture","https://secure.pipeline.soar.com/6141937-5c619c6c9aa946c425f4201dddb9f556/orig.mp4?Expires=1770505223&Signature=gYTB0O8mj-Bt-28QeBzuBQCtIeNvaO6U~R~gQNITznp7XbfN2oC~uuSVbAaKzoIQMRiH00eSCPxHbJoLFb6Bcrp-I9xKxnxQKP0iGcY-QrUnT~GNaBabFiJ~PJi8Uu1xsGO2VLZsOzHFypWCuSYaCs1V7Vs2yILlQHNX5GsaVM-MECURrlSnEfCHrPkXzOVtPIqh6bIYSAQErK4PNoPCdRcfAsHxlce663RXp4LwzerxKXAp6eaM3wLCYgMae2dYXK5m890BeWUzYaFh7IyrLQQz28hCfzO5Q2aowDKVCNPdftvTvdEkk5xmm14ODuFlJ0vq7n1HG5FDwYoIg1BIkQ__&Key-Pair-Id=KUT5TJCACFTXG","After more than three hours of debate, a Senate committee adopted a modified substitute for S.1498 — titled in the hearing the Pelosi Act — and then voted to report the bill as modified. The bill, as discussed, would bar members of Congress and other covered officials from buying or selling individual stock shares while in office and would require divestment or other compliance paths for officeholders by the start of their next term.

Senators debated whether the measure should apply immediately to the president and whether certain assets should be exempted. Senator Hawley (Senator Hawley) argued the public expects members of Congress not to trade individual shares and urged a “yes” vote on the bill. Opponents raised concerns about unintended consequences for small businesses and illiquid assets, the effect on recruiting private‑sector candidates, and enforcement of blind trusts. Senator Paul (Senator Paul) and others said the bill could force owners of illiquid businesses or family land to sell at an inopportune time; Senator Lankford (Senator Lankford), chair of the ethics committee, questioned elimination of qualified blind trusts and pressed for enforcement details.

A central procedural question in the markup was a modification to the substitute that changes how the president is treated. The committee first voted on the modification that would prevent immediate application of certain divestment requirements to the sitting president. That modification passed by voice/roll (announced as yeas 8, nays 6). Multiple secondary amendments were offered and rejected; one proposed study of specific historical trades was defeated, and a separate amendment to exempt the president and vice president also failed. The committee then adopted the Holly substitute as modified (vote announced yeas 8, nays 7) and the committee voted to report the bill as modified (final tally announced yeas 8, nays 7).

Supporters said the bill immediately prohibits trading and gives officeholders a transition period — typically until the beginning of their next term — to divest or come into compliance. Senator Slotkin (Senator Slotkin) and others explained that current blind trusts would be grandfathered for a transition period but the bill, as written in the committee substitute, phases divestment requirements so that current officeholders would have time to comply if reelected. Opponents repeatedly raised that the bill, in practice, would not apply to certain wealthy appointees or to the sitting president under the adopted modification.

The transcript shows several points of procedural confusion and concern among members about timing and the availability of the substitute text and the modification; at least one senator said the substitute was distributed electronically Friday and the modification was provided to most members only upon arrival at the markup. Members requested follow‑up drafting and enforcement guidance from the ethics committee staff and the bill’s sponsors. The committee then moved to nominations.","After extended debate, a Senate committee adopted a substitute and then passed S.1498 (the ‘‘Pelosi Act’’) as modified to prohibit trading in individual stocks by many federal officeholders; the committee adopted a modification that changes how the president is treated and set timelines for divestment for reelected officeholders.",{"_33":88,"_35":36,"_37":38,"_39":89,"_41":90,"_43":91,"_45":92,"_47":93,"_49":94,"_51":95,"_53":96,"_55":56,"_57":58,"_59":97,"_61":62,"_63":64,"_65":98,"_67":68,"_69":70,"_71":72,"_73":72,"_74":72},6141938,"Committee advances Royalty Transparency Act after members cite NIH royalty payments",497,1315000,1812000,"/Search/View?dp=1&key=5569697-a6a320e7ca35afd02dae6cb260887859&start=1315&end=1812","https://assets.pipeline.soar.com/5569697-a6a320e7ca35afd02dae6cb260887859/thumbnail_1315000.jpg","/articles/6141938/Committee-advances-Royalty-Transparency-Act-after-members-cite-NIH-royalty-payments","https://secure.pipeline.soar.com/6141938-a6aec6610dd0e96db181d0f312684fcb/orig.mp4?Expires=1770505223&Signature=fgOO2VmXtZzXTEkr1EjmaLKKp5vZVshnfhPJDGpiGJf66Bx1duYa85vATC3jphs8mdv3qMdBUKFT-gAdQmmOrDlPITxEEK1bi6U7Y1s2fHMvNpODGKv5ntSllwLrl-mdKbHtlzKLA69N8sb8qO1N2u-f3xfvC85wT50ebS~Sd9X~rxWaKyq0s~1WCxECbwwnxP2kDoYWgZMx0sW5AzDQKs0sc0WAE1TkBu4fGEmZsU6KOumJm5cNYryKmYbIDof7JUU7mG49d9EehLmQS-oi~uLD4T~p61js-5Di6XEcglqSceOz9bD9FEMHPV~nxDbVQwYRYZbErsAkcvmZ9tTbVw__&Key-Pair-Id=KUT5TJCACFTXG","The committee approved S.855, the Royalty Transparency Act, a reporting measure intended to increase disclosure of royalties received by government scientists. The sponsor said a Freedom of Information Act review found about 2,400 National Institutes of Health scientists received more than $300 million in royalty payments over the last decade, and argued public knowledge of royalty sources can reveal potential conflicts when scientists serve on advisory bodies.

The sponsor described the bill as a reporting requirement that passed the committee in the prior Congress without amendment and urged unanimous consideration. The clerk read the roll; the clerk announced the vote as yeas 13, nays 0 (with proxy yeas noted separately) and the motion was agreed to.

No amendments or extended debate were recorded in the transcript; the discussion focused on transparency of financial ties between researchers and outside entities. The transcript did not list implementation dates, enforcement mechanisms, or the specific reporting format to be used; those details would be developed later in committee or during floor consideration.

The transcript shows the committee moved through a series of additional bills after the Royalty Transparency Act vote.","A Senate committee approved S.855, the Royalty Transparency Act, after members cited a FOIA finding that thousands of NIH scientists received substantial royalty payments; committee action was unanimous as announced.",{"_33":100,"_35":36,"_37":38,"_39":101,"_41":102,"_43":103,"_45":103,"_47":104,"_49":105,"_51":106,"_53":107,"_55":56,"_57":58,"_59":108,"_61":62,"_63":64,"_65":109,"_67":68,"_69":70,"_71":72,"_73":72,"_74":72},6141943,"Committee approves Risky Research Review Act to create presidential panel for high‑risk life‑sciences work",0,552000,"/Search/View?dp=1&key=5569697-a6a320e7ca35afd02dae6cb260887859&start=552&end=552","https://assets.pipeline.soar.com/5569697-a6a320e7ca35afd02dae6cb260887859/thumbnail_552000.jpg","/articles/6141943/Committee-approves-Risky-Research-Review-Act-to-create-presidential-panel-for-highrisk-lifesciences-work","https://secure.pipeline.soar.com/6141943-3e1fee64524d68240f675759d4a1a53f/orig.mp4?Expires=1770505223&Signature=UGdBIFc~boZGKwdw724DLhFpSLCxu7~X3U8Y0PmgBANtiYrFPVOwvZBlCs0by9auq8U1eLj1WmY2X1vPds-B~KTeV-d4TFGPfhmlhFr3iKo38WJ78-hzohMujLjUZ2TafFdyc1NnEiGoK6gikOS2~fM2rcoRVW2gJcKiePl5jMKGp7D38mibCvQD1EKzgEGChVMyyvjSj2-z0ay6e4j9R0TfMQ0dwXH2cUHd3h2bB3YswD7Mm4v159MldgrsUqZhBsI0ADo~BN5eYmw8WD9CIqmeriVMvKCoHRtx7KObUywWxU2dYKxxqQFZp5T-wk1c7us~RBsijNS57X50bhqJ0Q__&Key-Pair-Id=KUT5TJCACFTXG","A Senate committee voted to advance S.854, the Risky Research Review Act, a measure to create a presidentially appointed panel to review high‑risk life‑sciences research and reduce conflicts of interest. The committee approved the bill by recorded voice/roll call and reported the motion agreed to after the tally showed more yeas than nays.

The measure’s sponsor told the committee the bill responds to concerns from U.S. intelligence agencies and the Department of Energy that COVID‑19 might have originated in a laboratory and to broader worries about risky research becoming possible by purchase of genetic material online. “We’re prompted to do this work because the CIA, the FBI, and the DOE all say with varying degrees of confidence that they fear COVID‑19 could have started as a lab leak,” the sponsor said, and cited an example raised in the hearing of a researcher who bought gene fragments online to recreate the Spanish flu.

The bill would establish a “high‑risk life sciences panel” appointed by the president and include conflict‑of‑interest protections, according to the sponsor’s description. Supporters said a permanent statutory review body would be preferable to an administrative ban because a law remains in place beyond a single administration.

Senator Peters (Senator Peters) voiced support during the markup. The clerk’s announcement reported the committee tally as yeas 11, nays 2 (with some proxy votes recorded separately) and the motion was agreed to.

No amendments were recorded in the transcript. The sponsor said the committee passed a similar version in the prior Congress by voice vote or unanimous consent (noted as 13–1 last Congress), and urged the committee to move the bill again.

Discussion only, direction to staff, and formal action were distinct in the transcript: members discussed reasons for statutory review, the sponsor described the panel’s conflict‑of‑interest goals, and the committee voted to report the bill. The transcript did not state implementation details such as membership criteria beyond the sponsor’s general description.

The committee moved on to subsequent agenda items after the vote; the transcript did not identify a schedule for floor consideration or any required follow‑up reporting tied to this committee action.","A Senate committee approved S.854, the Risky Research Review Act, to create a presidentially appointed panel to review high‑risk life‑sciences research and reduce conflicts of interest; supporters cited lab‑origin concerns and online availability of dangerous genetic material.","actionData","errors"]

Article not found

Committee reports four nominees to the Senate after roll‑call votes

Committee adopts modified ‘Pelosi Act’ banning members from owning individual stocks; modification exempts sitting president from required divestiture

Committee advances Royalty Transparency Act after members cite NIH royalty payments

Committee approves Risky Research Review Act to create presidential panel for high‑risk life‑sciences work